These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1942244)

  • 1. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.
    Parmar K; Huebner RC; Rosenberg N
    J Virol; 1991 Dec; 65(12):6478-85. PubMed ID: 1942244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abelson murine leukemia virus variants with increased oncogenic potential.
    Murtagh K; Skladany G; Hoag J; Rosenberg N
    J Virol; 1986 Nov; 60(2):599-606. PubMed ID: 3021994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Abelson murine leukemia virus pathogenesis.
    Green PL; Holland GD; Kaehler D; McKearn J; McCubrey J; Risser R
    Curr Top Microbiol Immunol; 1986; 132():62-74. PubMed ID: 3024924
    [No Abstract]   [Full Text] [Related]  

  • 6. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
    Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
    J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the Abelson murine leukemia virus transforming protein.
    Witte ON; Ponticelli A; Gifford A; Baltimore D; Rosenberg N; Elder J
    J Virol; 1981 Sep; 39(3):870-8. PubMed ID: 6270355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.
    Marchlik E; Kalman R; Rosenberg N
    J Virol; 2005 Sep; 79(18):11618-26. PubMed ID: 16140739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus.
    Prywes R; Hoag J; Rosenberg N; Baltimore D
    J Virol; 1985 Apr; 54(1):123-32. PubMed ID: 2983109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells.
    Grunwald DJ; Dale B; Dudley J; Lamph W; Sugden B; Ozanne B; Risser R
    J Virol; 1982 Jul; 43(1):92-103. PubMed ID: 6287020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.
    Poirier Y; Kozak C; Jolicoeur P
    J Virol; 1988 Nov; 62(11):3985-92. PubMed ID: 2845118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural alterations in the carboxyl-terminal domain of the BCRABL gene product activate its fibroblastic transforming potential.
    Shore SK; La Cava M; Yendapalli S; Reddy EP
    J Biol Chem; 1994 Feb; 269(7):5413-9. PubMed ID: 8106523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences.
    Dale B; Ozanne B
    Mol Cell Biol; 1981 Aug; 1(8):731-42. PubMed ID: 9279386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
    Clark SS; Liang Y; Reedstrom CK; Wu SQ
    Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
    Rosenberg N; Witte ON
    J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal effect of the Abelson murine leukemia virus transforming gene product.
    Ziegler SF; Whitlock CA; Goff SP; Gifford A; Witte ON
    Cell; 1981 Dec; 27(3 Pt 2):477-86. PubMed ID: 6101202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.